Cargando…
Indocyanine green as an alternative to radioisotope in breast cancer sentinel node biopsy: a single centre experience during COVID19.
Autores principales: | Pitsinis, Vassilis, Brown, Douglas, Elseedawy, Emad, Vinci, Alessio, Macaskill, Jane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562879/ http://dx.doi.org/10.1016/j.ejso.2020.11.254 |
Ejemplares similares
-
Comparative Study Between Radioisotope Uptake and Fluorescence Intensity of Indocyanine Green for Sentinel Lymph Node Biopsy in Breast Cancer
por: Kang, Byeongju, et al.
Publicado: (2022) -
Novel Dual Tracer Indocyanine Green and Radioisotope Versus Gold Standard Sentinel Lymph Node Biopsy in Breast Cancer: The GREENORBLUE Trial
por: Nguyen, Chu Luan, et al.
Publicado: (2023) -
Sentinel lymph node biopsy after neoadjuvant treatment of breast cancer using blue dye, radioisotope, and indocyanine green: Prospective cohort study
por: Chirappapha, Prakasit, et al.
Publicado: (2020) -
Sentinel node biopsy using indocyanine green in oral/oropharyngeal cancer
por: Peng, Hanwei, et al.
Publicado: (2015) -
Diagnostic Performance of Indocyanine Green Plus Methylene Blue Versus Radioisotope Plus Methylene Blue Dye Method for Sentinel Lymph Node Biopsy in Node-Negative Early Breast Cancer
por: Agrawal, Sanjit Kumar, et al.
Publicado: (2020)